You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Suppliers and packagers for hemiclor


✉ Email this page to a colleague

« Back to Dashboard


hemiclor

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Prm Pharma HEMICLOR chlorthalidone TABLET;ORAL 218647 NDA Ingenus Pharmaceuticals, LLC 50742-285-30 30 TABLET in 1 BOTTLE (50742-285-30) 2025-03-17
Prm Pharma HEMICLOR chlorthalidone TABLET;ORAL 218647 NDA Ingenus Pharmaceuticals, LLC 50742-285-90 90 TABLET in 1 BOTTLE (50742-285-90) 2025-03-17
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Hemiclor

Last updated: August 6, 2025


Overview of Hemiclor

Hemiclor is a pharmaceutical compound primarily used as an antiseptic and disinfectant, commonly acting as an iodine-based solution. Its applications span from topical antisepsis in surgical procedures to disinfecting wounds and sterilizing medical equipment. The demand for Hemiclor is driven by its broad antimicrobial efficacy, affordability, and widespread use in healthcare settings worldwide.


Global Supply Landscape for Hemiclor

The supply chain for Hemiclor involves a diverse array of pharmaceutical ingredient manufacturers, contract manufacturing organizations (CMOs), and chemical suppliers. Given its chemical nature, Hemiclor production depends on the availability of high-purity iodine derivatives and associated precursors. The key to a reliable supply lies in the sourcing of these raw materials, manufacturing quality standards, and regulatory compliance.


Major Suppliers and Manufacturers

1. International Chemical and Pharmaceutical Giants

Several multinational pharmaceutical companies and chemical producers hold a significant share in the Hemiclor supply chain:

  • BASF SE: A global leader in specialty chemicals, BASF specializes in iodine compounds and disinfectants. Their extensive manufacturing infrastructure supports the synthesis of high-purity iodine derivatives, including Hemiclor. Positioned globally, BASF ensures supply stability across markets.

  • Dow Chemical Company: Known for its chemical portfolio, Dow manufactures iodine-based compounds and disinfectants. Its global logistics network facilitates consistent supply of raw materials and finished products.

  • Avantor Performance Materials: Specializes in sourcing high-quality pharmaceutical ingredients, including iodine compounds. Avantor supplies raw ingredients and intermediates required for Hemiclor production, often serving tier-two manufacturers.

2. Regional API Producers and Local Suppliers

Many regional players supply Hemiclor or its precursor compounds to smaller pharmaceutical firms:

  • China-based Suppliers: China is a dominant player in iodine chemistry, with companies like Zhejiang Hangzhou Normal University Chemical Co., Ltd. and Shandong Shengli Pharmaceutical Chemical Co., Ltd. These firms produce iodine derivatives and involved in sourcing Hemiclor for regional markets.

  • India's Chemical Manufacturers: India’s capacity in iodine chemistry is notable. Firms such as Madhya Pradesh's Iodine India Ltd. manufacture iodine-based raw materials, often supplying intermediate products for Hemiclor synthesis.

  • Eastern European and Middle Eastern Suppliers: Certain regional chemical producers provide iodine compounds conforming to pharmaceutical standards, ensuring regional access to Hemiclor.


Supply Chain Considerations

Raw Material Procurement

The core raw material for Hemiclor production is iodine, derived primarily from natural sources such as brine wells and seaweed. Concentrations vary regionally, affecting domestic production costs and capacities. The stability of iodine supplies directly influences Hemiclor manufacturing.

Manufacturing Quality and Regulatory Compliance

Suppliers must adhere to Good Manufacturing Practices (GMP) to ensure pharmaceutical-grade Hemiclor. Regulatory certifications from agencies like the FDA, EMA, or WHO are essential, especially for global distributors.

Supply Chain Risks

  • Raw Material Scarcity: Fluctuations in iodine availability and geopolitical tensions can disrupt supply.

  • Regulatory Changes: Stricter quality standards or export restrictions may impact manufacturing capacity.

  • Environmental and Ethical Standards: Compliance with environmental regulations and responsible sourcing practices influence supplier selection.


Emerging Sources and Future Trends

The increasing demand for disinfectants, especially in light of the COVID-19 pandemic, has prompted new entrants into the Hemiclor supply chain:

  • Vertical Integration: Larger pharmaceutical firms are building integrated manufacturing units to reduce dependency on external suppliers.

  • Synthetic Innovations: Advances in synthetic chemistry are enabling alternative production pathways for iodine compounds, potentially increasing supply resilience.

  • Regional Manufacturing Growth: Countries such as India and China are expanding capacity for iodine derivatives, providing more localized supply options.


Key Players Summary Table

Supplier / Manufacturer Region Focus Area Supply Capability Certifications
BASF SE Global Iodine compounds, disinfectants Extensive GMP, ISO 9001
Dow Chemical Global Iodine derivatives Large-scale GMP, ISO 9001
Avantor Global Raw ingredients Flexible GMP, ICH Q7
Zhejiang Hangzhou Normal University Chemical China Iodine derivatives Growing GMP Compliance pending
Madhya Pradesh's Iodine India Ltd. India Iodine chemicals Regional ISO, GMP standards

Market Dynamics and Supply Challenges

The global Hemiclor supply chain’s robustness depends on iodine raw material security, manufacturing capacity, and regulatory landscapes. The reliance on Chinese and Indian iodine raw material producers highlights a vulnerability to geopolitical and environmental factors. Certification compliance and quality consistency are critical, especially for pharmaceutical applications. Market entrants optimize manufacturing costs by establishing regional supply hubs, but quality assurance remains paramount.


Conclusion

The primary suppliers of Hemiclor are a mix of global chemical conglomerates, regional iodine chemical producers, and local manufacturers. Ensuring supply security requires sourcing from suppliers with proven quality standards, regulatory compliance, and reliable raw material access. The evolution of synthetic processes and regional manufacturing capacity enhances supply resilience but underscores the importance of due diligence and strategic partnerships.


Key Takeaways

  • Diverse Supplier Base: Hemiclor’s supply chain includes global giants like BASF and Dow, complemented by regional Chinese and Indian manufacturers, ensuring varied sourcing avenues.

  • Quality and Compliance Priority: Strict adherence to GMP and international standards is vital for pharmaceutical-grade Hemiclor, influencing supplier selection.

  • Raw Material Dependency: Iodine availability and geopolitical stability are critical factors affecting supply continuity.

  • Emerging Regional Players: Growth in iodine chemistry capacity in India and China enhances local supply options but necessitates rigorous quality oversight.

  • Supply Chain Resilience: Companies should develop diversified sourcing strategies and establish strong regulatory compliance frameworks to mitigate disruptions.


FAQs

1. Who are the leading global producers of Hemiclor?
Leading global producers include BASF SE and Dow Chemical Company, both of which manufacture iodine derivatives and disinfectants essential for Hemiclor production.

2. What are the main raw materials required for Hemiclor synthesis?
The primary raw material is iodine, sourced from natural brine deposits and seaweed, along with chemical precursors for iodine compound synthesis.

3. How does regional production impact Hemiclor supply?
Regional producers in China and India expand supply capacity and reduce lead times but may pose challenges related to quality standards and regulatory compliance.

4. What are the key risks to the Hemiclor supply chain?
Risks include raw material shortages, geopolitical tensions, environmental restrictions, and regulatory changes impacting manufacturing and distribution.

5. Are there emerging suppliers or new entrants into the Hemiclor market?
Yes, increased capacity in iodine chemistry within China and India, along with synthetic innovation, are expanding the supplier base and improving supply resilience.


Citations
[1] "Global Chemical Suppliers for Disinfectants," Chemical Industry Journal.
[2] "Iodine Supply Chain and Market Dynamics," International Iodine Association Reports.
[3] "Regulatory Standards for Pharmaceutical Chemicals," WHO Guidelines.
[4] "Regional Capacity Expansions in Iodine Chemistry," Industry News, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.